Osprey Medical Inc (ASX:OSP)


right-arrow Created with Sketch. -0.005 (-0.89%)
MCAP $14.24M
Last trade 12.57pm 21/01/2022 20mins delayed

Latest Announcements

21/12/2021OSPOsprey Medical Inc
25/11/2021OSPOsprey Medical Inc
03/11/2021OSPOsprey Medical Inc
28/10/2021OSPOsprey Medical Inc
20/10/2021 Price SensitivePSOSPOsprey Medical Inc
14/10/2021OSPOsprey Medical Inc
13/10/2021OSPOsprey Medical Inc
11/10/2021OSPOsprey Medical Inc

Company Overview

Osprey Medical, Inc. is a commercial stage company, which is focused on protecting patients from the harmful effects of X-ray dye (contrast) used during commonly performed angiographic imaging procedures. The Company’s products include AVERT, AVERT Plus, the DyeVert NG, DyeVert Plus, and DyeVert Plus EZ Systems. The AVERT Plus System reduces and monitors the amount of contrast dye used in commonly performed heart and peripheral vascular procedures. The DyeVert System is a self-adjusting product that reduces the amount of contrast dye used in commonly performed heart and peripheral procedures. DyeVert interfaces with syringe-manifold systems. These technologies are available with the United States Food and Drug Administration cleared indication for dye volume reduction. Its dye reduction and monitoring technologies are designed to help physicians minimize dye usage and reduce kidney damage associated with the use of contrast media for common cardiovascular procedures.

OSP in the news

Osprey Medical (OSP) receives medical device licence (MDL) approval to expand its…
Despite the ongoing COVID-19 pandemic, Osprey Medical (OSP) has continued to rebound…
Medical device maker Osprey Medical (OSP) has been awarded a Supplier Horizon…
Medical device manufacturer Osprey Medical (OSP) has struck a deal to have…

Search Previous Announcements